DXCM and BSX Related Headlines
Go Back- Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'
- Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'
- BofA’s six MedTech picks for 2026 on strong earnings growth
- Oppenheimer sees stronger growth at Boston Scientific
